Alaunos Therapeutics (TCRT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Michael Wong resigned as Vice President, Finance of Alaunos Therapeutics, and Ferdinand Groenewald has been appointed in his stead through a consulting agreement effective immediately. Groenewald, a seasoned finance professional and CPA with extensive experience in various financial roles, will lead the company’s accounting and financial reporting for $15,000 per month plus expenses. His term is indefinite, with a 30-day termination notice by either party, and includes customary officer indemnification provisions. Groenewald’s prior roles include leadership positions at Muscle Maker, Inc., and board memberships at several Nasdaq-listed companies.
For further insights into TCRT stock, check out TipRanks’ Stock Analysis page.